Published in Lab Law Weekly, August 24th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Medicis Pharmaceutical.
Report 1: Medicis (NYSE:MRX) announced today that holders of the Company's 2.5% Contingent Convertible Notes due 2032 (the "Securities") have the right to surrender their Securities for purchase by Medicis pursuant to the terms of the indenture for the Securities (the "Option"). The Option expires on July 11, 2007.
The Option entitles each holder of the Securities to require Medicis to purchase all or any part of such holder's Securities at a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly